Benekli, M.; Gumus, M.; Ozkan, M.; Dane, F.; Elkiran, E.T.; Cicin, I.; Sevinc, A.; Aliustaoglu, M.; Isikdogan, A.; Meydan, N.; Oksuzoglu, B.; Ozyilkan, O.; Artac, M.; Ozdemir, F.; Kilickap, S.
(2021)
Objective: Cytokines have been the mainstay of treatment in metastatic renal cell cancer (mRCC) for decades before the introduction of tyrosine kinase inhibitors (TKIs), which dramatically changed the therapeutic landscape ...